Nick (anti-cancer drugs) Flashcards
Cancer treatment
There are three traditional approaches to the treatment of cancer:
- Surgery
- Radiotherapy
- Chemotherapy
Chemotherapy is often used alongside surgery and radiotherapy.
Combination therapy is used as this has increase efficacy of action, decreased toxicity and evasion of drug resistance.
As cancer cells are derived from normal cells, identifying targets unique to cancer cells is not easy.
Most traditional anticancer drugs work by disrupting the function of DNA and are classed as cytotoxic.
Mechanisms of action
There are various anti-cancer drugs with different mechanisms of action. These include:
- Alkylating and metalling agents
- Intercalating agents
- Topoisomerase poisons
- Chain cutters
- Chain terminators
These interact directly with DNA to inhibit its various functions.
Antimetabolites
Another way to disrupt DNA function is to inhibit the enzymes involved in the synthesis of DNA. These are antimetabolites. They include:
- Dihydrofolate reductase inhibitors
- Thymidylate syntheses inhibitors
- Ribonucleotide reductase inhibitors
- Adenosine deaminase inhibitors
- DNA polymerase inhibitors
Other types of chemotherapy
Anti-cancer drugs can also act on structural proteins such as tubulin, a structural protein crucial in cell division.
Paclitaxel binds to tubulin and causes cell division cycle to be halted. Used to treat cervical cancers.
Enzyme inhibition
Anti-cancer drugs can also inhibit enzymes involved in angiogenesis (formation of new blood vessels), metastasis and apoptosis.
These include matrix metalloproteinase inhibitors and many others.
MMPs are zinc dependant enzymes that degrade extracellular matrix and encourage angiogenesis, tumour propagation, and metastasis.
Receptor inhibition
Anti-cancer drugs can be used to inhibit receptors for growth hormones and the various signal proteins and kinases in the signal transduction pathways
Hormone based therapies, monoclonal antibodies, and gene therapy have also been used as anti-cancer agents
Alkylating agents
Contains highly electrophilic groups that form covalent bonds to nucleophilic groups in DNA.
They prevent replication and transcription and are useful anticancer agents. However, there can be toxic side effects.
Alkylating agents can cause interstrand (between bases on both strands) and intrastrand (between bases on the same strand) crosslinking if two electrophilic group present.
Alkylation of nucleic acid basses can result in miscoding.
Examples of alkylating agents
Nitrogen mustards are example of alkylating agents that cause interstrand and intrastrand crosslinking and prevents replication.
Nitrogen mustards mechanism of action
Chloromethine loses -Cl to become Aziridinium ion.
Lone pair on N in guanine attracted to C in ion.
Loses another -Cl.
Lone pair on N on guanine on other strand attracted to positive charge to form cross linked DNA.
Chlormethine
Chlormethine is highly reactive and can react with water, blood and tissues. It is too reactive to survive the oral route and must be administered intravenously.
Other nitrogen mustards used an anti-cancer drugs include:
- Melphalan
- Uracil mustard
- Estramustine
- Chlorambucil
- Ifosamide
Melphalan
Melphalan doesn’t undergo the side reactions like chlormethine because the benzene ring in melphalan is electron withdrawing via resonance so the lone pair on N is less available.
Melphalan’s structure mimics the amino acid phenylalanine meaning it is more likely to be recognised as an amino acid and get taken into cells by transport proteins.
Metallating agents
Metallation is a chemical reaction that forms a bond to a metal. Cis-platin is a metallating agent used to treat cancer.
Cisplatin
‘Cis’ is from the arrangement of the chlorines and ammonias (cis/trans).
It is activated in cells with low chloride concentration, causing chloroformed substituents to be replaces with neutral water ligands, forming a positively charged species.
Cl leaves molecules. Lone pair on O in H2O attracted to Pt and replaces that ligand. Same thing happens with other Cl and a 2+ species is formed. DNA replaces the water ligands.
Cisplatin binds to DNA in regions rich in guanine units and causes intrastrand crosslinks rather than interstrand crosslinks.
This causes localised unwinding of DNa double helix and inhibits transcription.
Alkylating and metallating agents summary points
Alkylating agents contain electrophilic groups that react with nucleophilic centres in DNA. If two electrophilic groups are present, interstrand crosslinking of the DNA is possible.
Nitrogen mustards react with guanine groups on DNA to produce crosslinking.
Nitrogen mustards reactivity can be lowered by adding electron withdrawing groups to the N.
Incorporation of biosynthetic building blocks aids the uptake into rapidly dividing cells.
Cisplatin and its analogues are metallating agents which cause intrastrand crosslinking. They are commonly used for the treatment of testicular and ovarian cancers.
Intercalating agents
Intercalating agents contain planar aromatic or heteroaromatic ring systems. (Flat so it can get between layers and disrupt bonding in helix).
These planar systems slip between the layers of nucleic acid pairs and disrupt the shape of the helix.
Intercalation prevents replication and transcription.